Seeking Alpha

Around 2,000 jobs at Sanofi (SNY -2.6%) could be at risk as part of the firm's plans to...

Around 2,000 jobs at Sanofi (SNY -2.6%) could be at risk as part of the firm's plans to consolidate its French R&D ops, a company union says. Sanofi plays down the fears, but says it's looking to build "research ecosystems" around Paris, Lyon and Strasbourg. Sanofi has already chopped 4,000 jobs in France in the past three years.
Comments (1)
  • op59no3
    , contributor
    Comments (5) | Send Message
     
    This company is going to implode:
    - their top management is bloated and overpaid
    - they are dumping 1000s of rank and file scientists who actually do research
    - the best employees from the recent Genzyme buyout have left a while ago; the remaining employees are so demoralized from continual indecision and poor planning they can't produce much of anything

     

    While they may have a few quarters left of big revenue, ultimately, they have no future.
    6 Jul 2012, 06:34 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs